METHOD OF CANCER PROGNOSIS BY ASSESSING TUMOR VARIANT DIVERSITY

摘要

The invention is a method of predicting response to therapy in a colorectal cancer patient, the method comprising measuring tumor genetic heterogeneity via analysis of circulating tumor DNA from a patient's sample.